Stiff-man syndrome (SMS) is a rare disease of progressive muscle stiffness, most common in middle age, often associated with autoimmunity to glutamic acid decarboxylase (GAD) and responsive to treatment with GABA agonists. Diagnosis is established by clinical characteristics and confirmed by EMG or antibody testing. Anti-GAD antibodies are present in 60% of those with SMS and antiamphiphysin antibodies are found in fewer than 10%. The production of antibodies has an unclear relationship to the pathological processes of the disease. GABA receptors and GABA receptor mRNAs are found in high density in the spinal cord laminae and identify possible sites of dys-function in SMS. At some spinal cord synapses, GABA co-localizes with glycine, a neurotransmitter implicated in hyperekplexia. Failure of spinal cord reflexes explains the symptoms of SMS, but electrophysiological studies have not yet identified a single locus of inhibitory failure. Immunomodulation may alter the disease course, but consistently effective treatments for SMS await development.
Moersch FP, Woltman HW. Progressive fluctuating muscular rigidity and spasm (“stiff-man” syndrome): report of a case and some observations in 13 other cases. Proc Mayo Clin1956;31:421-427.
2.
Lorish TR, Thorsteinsson G, Howard FM. Stiff-man syndrome updated. Mayo Clin Proc1989;64:629-636.
3.
Gordon EE, Januszko DM, Kaufman L. A critical survey of stiff-man syndrome. Am J Med1967;42:582-599.
4.
Blum P, Jankovic J. Stiff-person syndrome: an autoimmune disease. Mov Disord1991;6:12-20.
5.
Solimena M, Folli F, Denie-Donini S, Comi GC, Pozza G, DeCamilli P, et al.Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med1988;318: 1012-1020.
6.
Vicari AM, Folli F, Pozza G, Comi GC, Comola M, Canal N, et al.Plasmapheresis in the treatment of stiff-man syndrome. N Engl J Med1989;320:1499.
7.
Solimena M, Folli F, Aparisi R, Poxxa G, DeCamilli P. Autoantibodies to gaba-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med1990;322:1555-1560.
8.
Walikonis JE, Lennon VA. Radioimmunoassay for glutamic acid decaboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type I diabetes mellitus. Mayo Clin Proc1998;73:1161-1166.
9.
Folli F, Solimena M, Cofiell R, DeCamilli P. Autoantibodies to a 128 kD synaptic protein in stiff-man syndrome with breast cancer. N Engl J Med1993;328:546-551.
10.
Rosin L, DeCamilli P, Butler M, Solimena M, Schmitt H-P, Morgenthaler N, et al.Stiff man syndrome in a woman with breast cancer: an uncommon central nervous system paraneoplastic syndrome. Neurol1998;50:94-98.
11.
281:419-424.
12.
Howard FM Jr.A new and effective drug in the treatment of the stiff-man syndrome: preliminary report. Mayo Clin Proc1963;38:203-212.
13.
Dinkel K, Meinck H-M, Jury KM, Karges W, Richter W. Inhibition of γ-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol1998;44:194-201.
14.
Toro C, Jacobowitz DM, Hallett M. Stiff-man syndrome. Semin Neurol1994;14:154-158.
15.
Zekzer D, Wong FS, Ayalon O, Millet I, Altieri M, Shintani S, et al.GAD-reactive CD4+Th1 cells induce diabetes in NOD/SCID mice. J Clin Invest1998;101:68-73.
16.
Jonas P, Bischofberger J, Sandkuhler J. Corelease of two fast neurotransmitters at a central synapse. Science1998;281: 419-424.
17.
Todd AJ, Watt C, Spike RC, Sieghart W. Colocalization of GABA, glycine and their receptors at synapses in the rat spinal cord. J Neurosci1996;16:974-982.
18.
Brown P. Myoclonus. Curr Opin Neurol1996;9:314-316.
19.
Shiang R, Ryan SG, Zhu Y-Z, Fielder TJ, Allen RJ, Fryer A, et al.Mutational analysis of familial and sporadic hyperekplexia. Ann Neurol1995;38: 85-91.
20.
Author A. Movement disorders. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in clinical practice, principles of diagnosis and management. 2d ed.Boston, MA: Butterworth-Heinemann; 1996. p. 1763.
21.
Yoshimura M, Nishi S. Primary afferent-evoked glycine-and GABA-mediated IPSPs in substantia gelatinosa neurones in the rat spinal cord in vitro. J Physiol1995;482:29-38.
22.
Schoenen J, Faull RLM. Spinal cord: chemoarchitectural organization. In: Paxinos G, editor. The human nervous system. London: Academic Press; 1990. p. 55-75.
23.
Persohn E, Malherbe P, Richards JG. In situ hybridization histochemistry reveals a diversity of GABAA receptor subunit mRNAs in neurons of the rat spinal cord and dorsal root ganglia. Neuroscience1991;42:497-507.
24.
Malcangio M, Bowery NG. GABA and its receptors in the spinal cord. Trends Pharmacol Sci1996;17:457-462.
25.
Mitsumoto H, Schwartzman MJ, Estes ML, Chou SM, LaFranchise EF, DeCamilli P, et al.Sudden death and paroxysmal autonomic dysfunction in stiff-man syndrome. J Neurol1991;238:91-96.
26.
Meinck HM, Ricker K, Hulser P-J, Solimena M. Stiff man syndrome: neurophysiological findings in eight patients. J Neurol1995;242:134-142.
27.
Floeter MK, Valls-Sole J, Toro C, Jacobowitz D, Hallett M. Physiologic studies of spinal inhibitory circuits in patients with stiff-person syndrome. Neurol1998;51:85-93.
28.
Kissel JT, Elble RJ. Stiff-person syndrome, stiff opposition to a simple explanation. Neurol1998;51:11-14.
29.
Barr ML, Kiernan JA. The spinal cord. In: The human nervous system, an anatomical viewpoint. 6th ed.Philadelphia: Lippincott. p. 73-84.
30.
Brashear HR, Phillips LH II. Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome. Neurol1991;41:1588-1592.
31.
Hart IK, Waters C, Vincent A, Newland C, Beeson D, Pongs O, et al.Autoantibodies detected to expressed K channels are implicated in neuromyotonia. Ann Neurol1998;41:238-246.
